These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5345903)

  • 1. Efficacity in experimental induced liver damage of a natural polypeptide.
    Timar M; Hädrich I; Vrejoiu G; Teodorescu M; Szegli G; Nitelea I
    Biochem Pharmacol; 1969 Sep; 18(9):2278-9. PubMed ID: 5345903
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigations on the effect of liver preparations.
    Magyar I
    Acta Med Acad Sci Hung; 1968; 25(3):323-30. PubMed ID: 5720863
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the antihepatotoxic effect of a liver extract as illustrated in the model of a rat liver damaged by carbon tetrachloride].
    Pappas A; Schwarze G; Veleris-Triandafyllou J
    Med Welt; 1974 Jan; 25(4):150-2. PubMed ID: 4822929
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of sirepar on the functional state of the liver in experimental toxic hepatitis caused by carbon tetrachloride].
    Oleĭnik AN; Skakun LN
    Vrach Delo; 1975 Jun; (6):13-4. PubMed ID: 1154722
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE LIVER PROTECTIVE EFFECT OF CYSTEINE, HOMOCYSTEINE THIOLACTONE AND N-ACETYLHOMOCYSTEINE THIOLACTONE IN EXPERIMENTAL LIVER DAMAGE].
    VARGA F; MEHES J; MOLNAR Z
    Arzneimittelforschung; 1963 Oct; 13():867-71. PubMed ID: 14196762
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic excretion and storage of sulfobromophthalein sodium in experimental hepatic necrosis in the dog.
    Himes JA; Cornelius CE
    Cornell Vet; 1973 Jul; 63(3):424-31. PubMed ID: 4782559
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of the biological value of liver-protective agents with special reference to liver preparations. 8. Description of the method for the biological evaluation of preventive and therapeutic liver-protective agents].
    Dressel H
    Z Med Labortech; 1969; 10(6):371-84. PubMed ID: 5405586
    [No Abstract]   [Full Text] [Related]  

  • 8. TOLERANCE TO CARBON TETRACHLORIDE IN CARBON TETRACHLORIDE-INDUCED CIRRHOSIS.
    WONG J; FINCKH ES
    J Pathol Bacteriol; 1965 Apr; 89():611-7. PubMed ID: 14320304
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of a liver prophylactic substance on trinitrotoluene poisoning].
    Ruzdić N; Stern P
    Wien Klin Wochenschr; 1966 Oct; 78(40):669-70. PubMed ID: 5972533
    [No Abstract]   [Full Text] [Related]  

  • 10. [Excretion of 131I-labeled bromsulphalein in rats with experimental liver injury].
    Hrncír E; Hykes P; Friedman B
    Sb Lek; 1986 Feb; 88(2):33-41. PubMed ID: 3961415
    [No Abstract]   [Full Text] [Related]  

  • 11. [BLOOD CLEARANCE OF SULFOBROMOPHTHALEIN IN MICE IN EXPERIMENTAL ACUTE HEPATITIS].
    COQUET B; CIER A; FRANDON A
    C R Seances Soc Biol Fil; 1964; 158():2141-5. PubMed ID: 14282134
    [No Abstract]   [Full Text] [Related]  

  • 12. Hexobarbital sleeping time in male rats with hepatic injury.
    Varga F; Fischer E
    Acta Physiol Acad Sci Hung; 1969; 36(4):431-9. PubMed ID: 5376036
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the prevention and cure of experimentally induced functional and morphological liver changes.
    Neukomm S; Kiraly M
    Arzneimittelforschung; 1967 Sep; 17(9):1135-42. PubMed ID: 5632288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of action of carbon tetrachloride on the power of elimination of bromosulfonophthalein of the liver].
    Haller PH
    C R Acad Hebd Seances Acad Sci D; 1970 Nov; 271(19):1686-8. PubMed ID: 4994402
    [No Abstract]   [Full Text] [Related]  

  • 15. [EVALUATION OF HEPATIC LESIONS OF VARIOUS ORIGINS BY MEANS OF FUNCTION TESTS. I. TREATMENT WITH CARBON TETRACHLORIDE].
    ANGELICO R; CAVINA G; D ANTONA A; MANGANARO M
    Boll Soc Ital Biol Sper; 1963 Dec; 39():1788-91. PubMed ID: 14150805
    [No Abstract]   [Full Text] [Related]  

  • 16. New studies on the prevention and cure of experimental hepatic dysfunction. 1.
    Rohn S; Kiraly M; Neukomm S
    Arzneimittelforschung; 1967 Jan; 17(1):47-9. PubMed ID: 5632526
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of homologous hepatic RNA on liver collagen and tryptophan pyrrolase in CC1-4 poisoning in rats].
    Chernukh AM; Vyshepan ED; Shukalova TF; Alekseeva NN; Razumova IL
    Biull Eksp Biol Med; 1971 Jun; 71(6):43-6. PubMed ID: 5097378
    [No Abstract]   [Full Text] [Related]  

  • 18. Some clinical and experimental observations on serum peptidase activity in hepatic disorders.
    Horký J; Placer Z; Sousek O
    Clin Chim Acta; 1967 May; 16(2):279-85. PubMed ID: 6033519
    [No Abstract]   [Full Text] [Related]  

  • 19. [The behavior of the sulfobromophthalein chromoelimination curves subjects with ethylic hepatopathy treated with a liver extract enriched with nucleosides of the pyrimidine series and ith cyanocobalamine].
    D'Agostino F
    Minerva Med; 1970 Oct; 61(87):4893-901. PubMed ID: 5488540
    [No Abstract]   [Full Text] [Related]  

  • 20. [Patterns of rat liver damage following intrasplenic injection of differentially dispersed carbon tetrachloride].
    Jäger J; Justus J; Anders L
    Zentralbl Allg Pathol; 1971; 114(3):303-8. PubMed ID: 5283791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.